
MedIndia
<img alt="" height="1" width="1" />
Sanofi announces positive results for diabetes drug
Reuters
PARIS (Reuters) - French drugmaker Sanofi said a late-stage study of its lixisenatide drug in combination with Lantus insulin showed a significant improvement in blood sugar levels and a beneficial effect on body weight in type 2 diabetes patients. ...
Sanofi Reports Positive Results For Lyxumia With Lantus In Type 2 DiabetesRTT News
Sanofi's Add-on Type 2 Diabetes Therapy Lyxumia Meets Phase III Trial EndpointNASDAQ
Positive Results Reported by Sanofi for Once-Daily Lixisenatide (Lyxumia(R) 1 ...MarketWatch (press release)
The FINANCIAL -Medical Xpress -Pharmaceutical Business Review
all 46 news articles »
More...